RSRoger Stenling

Roger Stenling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roger Stenling has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    COL11A1 in FAP polyps and in sporadic colorectal tumors

    by Heléne Fischer, Sima Salahshor, Roger Stenling, Jan Björk, Gudrun Lindmark, Lennart Iselius, Carlos Rubio, Annika Lindblom

    We previously reported that the α-1 chain of type 11 collagen (COL11A1), not normally expressed in the colon, was up-regulated in stromal fibroblasts in most sporadic colorectal carcinomas. Patients with germline mutations in the APC gene show, besides colonic polyposis, symptoms of stromal fibroblast involvement, which could be related to COL11A1 expression. Most colorectal carcinomas are suggested to be a result of an activated Wnt- pathway, most often involving an inactivation of the APC gene or activation of β-catenin. We used normal and polyp tissue samples from one FAP patient and a set of 37 sporadic colorectal carcinomas to find out if the up-regulation of COL11A1 was associated with an active APC/β-catenin pathway. In this study we found a statistically significant difference in COL11A1 expression between normal tissue and adenomas from one FAP patient, and all adenomas gave evidence for an active APC/β-catenin pathway. An active Wnt pathway has been suggested to involve stromal expression of WISP-1. We found a strong correlation between WISP-1 and COL11A1 expression in sporadic carcinomas. Our results suggest that expression of COL11A1 in colorectal tumors could be associated with the APC/β-catenin pathway in FAP and sporadic colorectal cancer.


  • Open Access

    Differential expression of Aquaporin 8 in human colonic epithelial cells and colorectal tumors

    by Heléne Fischer, Roger Stenling, Carlos Rubio, Annika Lindblom

    The gene expression pattern in tumor cells differs from that in corresponding normal cells. In order to identify differentially expressed genes in colorectal tumors and normal colorectal epithelium, a differential display experiment was used to compare RNA expression in normal and tumor tissue samples. One gene fragment was expressed only in normal tissue and not, or to a much lesser extent, in the adenomas, carcinomas and cancer cell lines. The isolated gene fragment was identical to Aquaporin 8 (AQP8), a water channel protein. In situ hybridization demonstrated that AQP8 was expressed in the cells facing the lumen in the normal colonic epithelium. Our result suggests that the expression of AQP8 is a marker of normal proliferating colonic epithelial cells and suggest these cells to be involved in fluid transport in the colon.


  • Open Access

    DNA Aneuploidy in Ulcerative Colitis and in Colorectal Carcinoma – A Comparative Study

    by Roger Stenling, Bernt O. Jonsson, Richard Palmqvist, Jörgen N. Rutegård

    DNA aneuploidy is of interest as an additive marker for carcinoma risk in ulcerative colitis. It is known that colorectal carcinomas often are aneuploid with DNA indices centered around a median value of 1.5, corresponding to triploidy, and that adenomas, if aneuploid, have DNA indices closer to 2.0, the tetraploid region. In a colonoscopic surveillance programme, colorectal mucosal biopsies from 104 patients with ulcerative colitis were examined by flow cytometry, and the DNA indices determined and compared with findings of cellular dysplasia. In 17 patients, DNA aneuploidy was diagnosed, with DNA indices ranging from 1.2 to 2.0, median 1.9. Three patients with high grade dysplasia all had DNA indices within the triploid region. These results were compared with the DNA indices from a group of 49 patients with non‐colitis‐associated aneuploid colorectal carcinomas, in which the levels ranged from 1.1 to 2.0 with a median value of 1.5. Accordingly, the DNA index in the colitis patients with aneuploidy was more often within the tetraploid region. These results, obtained in patients with ulcerative colitis, indicate a possible precancerous progress from diploidy over tetraploidy to triploidy also in patients with long‐standing ulcerative colitis. In addition, the results speak in favour of a connection between DNA indices in the triploid region and more profound premalignant alterations.


    • 1 November 1997
      • Vol. 84  (11) , 1544-5

    Lateral rectal ligaments contain important nerves.

    by J Rutegård, B Sandzén, R Stenling, J Wiig, R J Heald


    • 1 October 1993
      • Vol. 40  (5) , 467-70

    Prognosis after early onset of ulcerative colitis. A study from an unselected patient population.

    by L Ahsgren, B Jonsson, R Stenling, J Rutegård

    All patients with onset of ulcerative colitis before the age of 20 years from a population of 65,000 inhabitants were studied. The study period was 30 years (1961 through 1990). There were 32 patients, 18 male and 14 female, giving an incidence of 0.7 patients/100,000/year. Twenty-four patients had total colitis and 8 had limited disease. The observed duration of the disease was 0-30 (mean 18, median 20) years. One patient died of fulminant disease. No colorectal carcinoma was diagnosed. In 7 patients, low-grade dysplasia was diagnosed, which did not progress during an observation period of 2-10 years. DNA aneuploidy was detected in 6 patients. Seven patients (22%) were operated on after a disease duration of 0-10 (mean 4, median 3) years on clinical grounds. No cancer-prophylactic colectomy was performed. It is concluded that, in an unselected population of patients with early onset of ulcerative colitis, mortality and cancer risk are low. The need for operative treatment during the first 15 years of the disease was around 22 per cent. Endoscopic surveillance was given preference over prophylactic colectomy in patients with low-activity or quiescent disease.


    • 1 August 1989
      • Vol. 36  (4) , 205-8

    DNA content in ulcerative colitis.

    by J Rutegård, R Stenling

    • 27 April 1988
      • Vol. 85  (17) , 1508-10

    [Ulcerative colitis and the risk of cancer. A suggestion for a follow-up program].

    by J Rutegård, L Ahsgren, L O Andersson, R Stenling, K G Janunger